Navigation Links
triniti(TM) Skin Treatment to be Featured in Keeping Up with The Kardashians Episode
Date:5/11/2009

Kris Jenner receives non-surgical treatment by Syneron(TM)

IRVINE, Calif., May 11 /PRNewswire-FirstCall/ -- Kris Jenner, entrepreneur, talent manager, socialite, celebrity and co-star of the E! show Keeping up with the Kardashians, will receive the triniti(TM) skin treatment (http://www.trinitiskin.com), a treatment that dramatically reduces signs of aging, during the May 17 episode airing at 10/9c.

The triniti skin treatment is a 3-in-1 non-surgical procedure for skin tightening with ReFirme, color correction with FotoFacial RF and deep wrinkle treatment with Syneron's Matrix series.

In this episode, Kris and her husband, former Olympian Bruce Jenner, debate a surgical or non-surgical makeover. Kris opts not to get plastic surgery and visits Dr. John Shieh of RejuvaYou Medical Spas in Pasadena, California, to experience the latest in skin rejuvenation treatments.

"Many of my patients, especially in this economy, are opting out of going under the knife and instead choose non-surgical alternatives like laser treatments," said Dr. Shieh. "Women don't want the tight and plumped, overdone look and are using laser-based treatments like triniti skin treatment to achieve and maintain their desired appearance without the downtime and/or complications associated with surgical procedures."

With three treatments, each spaced four weeks apart, the triniti skin treatment, developed by Syneron(TM) Medical Ltd. (Nasdaq: ELOS), encourages collagen production and new skin cell growth.

To find a triniti skin treatment provider near you or for more information, please visit http://www.trinitiskin.com. Catch new episodes of Keeping up with the Kardashians Sundays at 10/9c only on E!.

About Syneron

Syneron Medical Ltd. (Nasdaq: ELOS) manufactures and distributes medical aesthetic devices that are powered by the proprietary, patented elos(TM) combined-energy technology of bi-polar radio frequency and light. The Company's innovative elos technology provides the foundation for highly effective, safe and cost-effective systems that enable physicians to provide advanced solutions for a broad range of medical-aesthetic applications including hair removal, wrinkle reduction, rejuvenating the skin's appearance through the treatment of superficial benign vascular and pigmented lesions, cellulite, circumferential reduction and the treatment of acne, leg veins and laser-assisted lipolysis. Founded in 2000, the corporate, R&D, and manufacturing headquarters for Syneron Medical Ltd. is located in Israel. Syneron has offices and distributors throughout the world, including North American headquarters in Irvine, California, and Asia-Pacific headquarters in Hong Kong, which provide sales, service and support. Additional information can be found at http://www.syneron.com.

Syneron, the Syneron logo, triniti skin, ReFirme, Matrix IR, Matrix RF, FotoFacial RF and elos are trademarks of Syneron Medical Ltd. and may be registered in certain jurisdictions. Elos (Electro-Optical Synergy) is a proprietary technology of Syneron Medical. All other names are the property of their respective owners.


'/>"/>
SOURCE Syneron Medical Ltd.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. New treatment effective in counteracting cocaine-induced symptoms
2. New treatment boosts muscle function in myasthenia gravis
3. Broad-based group of physicians calls for improvement in stroke treatment
4. Cranberry Could Juice Up Ovarian Cancer Treatment
5. Non-medicinal treatment touted for pre-schoolers with ADHD
6. Nonmedicinal treatment touted for preschoolers with ADHD
7. U of M study: Early treatment can reverse heart damage
8. Biologic treatment for rheumatoid arthritis and the risk of cancer
9. New Treatment Explored for Cluster Headaches
10. Thailand: Partners Open Free AIDS Treatment Clinic in Renowned AIDS Temple in Lop Buri
11. 4-Star Gen. Barry Mccaffrey, Former U.S. Drug Czar, to Keynote Recovery Happens! Rally for Treatment: Wed., Sept. 5, 11 Am, State Capitol West Steps, Sacramento
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2016)... ... May 26, 2016 , ... Despite last week’s media reports hinting ... and company to wait until March 2017 for an interest rate increase, according to ... College of Business. , “The Federal Open Market Committee (FOMC) dot charts are of ...
(Date:5/26/2016)... Missouri (PRWEB) , ... May 26, 2016 , ... ... quality and clinical outcomes, hosted members and suppliers for its inaugural Member Conference ... focus on their mission of elevating the operational health of America’s healthcare providers. ...
(Date:5/26/2016)... Pompano Beach, Florida (PRWEB) , ... May 26, 2016 , ... ... Green House® Project offering a new model of care for living and ... on three core values: Meaningful Life in a Real Home provided by Empowered Staff. ...
(Date:5/26/2016)... , ... May 26, 2016 , ... ... and development solutions for drugs, biologics, consumer health and global clinical supply services, ... in Korea to support the company’s continued investment and strategic growth plans in ...
(Date:5/26/2016)... ... 26, 2016 , ... Memorial Day Weekend marks the unofficial start of summer ... tips to make sure your family and vehicle are ready to hit the road ... be 439 deaths and an additional 50,500 serious injuries from motor vehicle crashes during ...
Breaking Medicine News(10 mins):
(Date:5/26/2016)... Tenn. , May 26, 2016 /PRNewswire/ ... of software and analytics, network solutions and ... today announced it entered into a strategic ... provider of outpatient software solutions and revenue ... centers, specialty hospitals and rehabilitation clinics to ...
(Date:5/25/2016)... -- FDA 510(k) clearance covers Confocal ... urological and surgical applications Mauna Kea ... the multidisciplinary confocal laser endomicroscopy (CLE) platform, today ... with the 12 th 510(k) clearance from ... new FDA clearance covers Confocal Miniprobes indicated for ...
(Date:5/25/2016)... , Deutschland und GERMANTOWN, Maryland ... Zusammenarbeit mit Therawis bedient dringenden ... Brustkrebs   QIAGEN N.V. (NASDAQ: ... heute bekannt, eine Lizenz- und Entwicklungsvereinbarung mit Therawis ... für die Onkologie eingegangen zu sein. Ein erstes ...
Breaking Medicine Technology: